Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso
(1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the healt...
Ausführliche Beschreibung
Autor*in: |
Massa dit Achille Bonko [verfasserIn] Palpouguini Lompo [verfasserIn] Marc Christian Tahita [verfasserIn] Francois Kiemde [verfasserIn] Ibrahima Karama [verfasserIn] Athanase M. Somé [verfasserIn] Petra F. Mens [verfasserIn] Sandra Menting [verfasserIn] Halidou Tinto [verfasserIn] Henk D. F. H. Schallig [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2021 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Antibiotics - MDPI AG, 2013, 10(2021), 4, p 444 |
---|---|
Übergeordnetes Werk: |
volume:10 ; year:2021 ; number:4, p 444 |
Links: |
---|
DOI / URN: |
10.3390/antibiotics10040444 |
---|
Katalog-ID: |
DOAJ074352482 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ074352482 | ||
003 | DE-627 | ||
005 | 20240412184040.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/antibiotics10040444 |2 doi | |
035 | |a (DE-627)DOAJ074352482 | ||
035 | |a (DE-599)DOAJ25625a380afa46c09898852a92221a7c | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RM1-950 | |
100 | 0 | |a Massa dit Achille Bonko |e verfasserin |4 aut | |
245 | 1 | 0 | |a Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a (1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. | ||
650 | 4 | |a antibiotics | |
650 | 4 | |a resistance | |
650 | 4 | |a nasopharynx | |
650 | 4 | |a children | |
650 | 4 | |a <i<Streptococcus pneumoniae</i< | |
650 | 4 | |a <i<Staphylococcus aureus</i< | |
653 | 0 | |a Therapeutics. Pharmacology | |
700 | 0 | |a Palpouguini Lompo |e verfasserin |4 aut | |
700 | 0 | |a Marc Christian Tahita |e verfasserin |4 aut | |
700 | 0 | |a Francois Kiemde |e verfasserin |4 aut | |
700 | 0 | |a Ibrahima Karama |e verfasserin |4 aut | |
700 | 0 | |a Athanase M. Somé |e verfasserin |4 aut | |
700 | 0 | |a Petra F. Mens |e verfasserin |4 aut | |
700 | 0 | |a Sandra Menting |e verfasserin |4 aut | |
700 | 0 | |a Halidou Tinto |e verfasserin |4 aut | |
700 | 0 | |a Henk D. F. H. Schallig |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Antibiotics |d MDPI AG, 2013 |g 10(2021), 4, p 444 |w (DE-627)726120596 |w (DE-600)2681345-2 |x 20796382 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2021 |g number:4, p 444 |
856 | 4 | 0 | |u https://doi.org/10.3390/antibiotics10040444 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/25625a380afa46c09898852a92221a7c |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/2079-6382/10/4/444 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2079-6382 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 10 |j 2021 |e 4, p 444 |
author_variant |
m d a b mdab p l pl m c t mct f k fk i k ik a m s ams p f m pfm s m sm h t ht h d f h s hdfhs |
---|---|
matchkey_str |
article:20796382:2021----::niitcucpiiiyfsahlccuaruinitetccupemnaisltsrmhnspayxferl |
hierarchy_sort_str |
2021 |
callnumber-subject-code |
RM |
publishDate |
2021 |
allfields |
10.3390/antibiotics10040444 doi (DE-627)DOAJ074352482 (DE-599)DOAJ25625a380afa46c09898852a92221a7c DE-627 ger DE-627 rakwb eng RM1-950 Massa dit Achille Bonko verfasserin aut Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier (1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< Therapeutics. Pharmacology Palpouguini Lompo verfasserin aut Marc Christian Tahita verfasserin aut Francois Kiemde verfasserin aut Ibrahima Karama verfasserin aut Athanase M. Somé verfasserin aut Petra F. Mens verfasserin aut Sandra Menting verfasserin aut Halidou Tinto verfasserin aut Henk D. F. H. Schallig verfasserin aut In Antibiotics MDPI AG, 2013 10(2021), 4, p 444 (DE-627)726120596 (DE-600)2681345-2 20796382 nnns volume:10 year:2021 number:4, p 444 https://doi.org/10.3390/antibiotics10040444 kostenfrei https://doaj.org/article/25625a380afa46c09898852a92221a7c kostenfrei https://www.mdpi.com/2079-6382/10/4/444 kostenfrei https://doaj.org/toc/2079-6382 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 444 |
spelling |
10.3390/antibiotics10040444 doi (DE-627)DOAJ074352482 (DE-599)DOAJ25625a380afa46c09898852a92221a7c DE-627 ger DE-627 rakwb eng RM1-950 Massa dit Achille Bonko verfasserin aut Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier (1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< Therapeutics. Pharmacology Palpouguini Lompo verfasserin aut Marc Christian Tahita verfasserin aut Francois Kiemde verfasserin aut Ibrahima Karama verfasserin aut Athanase M. Somé verfasserin aut Petra F. Mens verfasserin aut Sandra Menting verfasserin aut Halidou Tinto verfasserin aut Henk D. F. H. Schallig verfasserin aut In Antibiotics MDPI AG, 2013 10(2021), 4, p 444 (DE-627)726120596 (DE-600)2681345-2 20796382 nnns volume:10 year:2021 number:4, p 444 https://doi.org/10.3390/antibiotics10040444 kostenfrei https://doaj.org/article/25625a380afa46c09898852a92221a7c kostenfrei https://www.mdpi.com/2079-6382/10/4/444 kostenfrei https://doaj.org/toc/2079-6382 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 444 |
allfields_unstemmed |
10.3390/antibiotics10040444 doi (DE-627)DOAJ074352482 (DE-599)DOAJ25625a380afa46c09898852a92221a7c DE-627 ger DE-627 rakwb eng RM1-950 Massa dit Achille Bonko verfasserin aut Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier (1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< Therapeutics. Pharmacology Palpouguini Lompo verfasserin aut Marc Christian Tahita verfasserin aut Francois Kiemde verfasserin aut Ibrahima Karama verfasserin aut Athanase M. Somé verfasserin aut Petra F. Mens verfasserin aut Sandra Menting verfasserin aut Halidou Tinto verfasserin aut Henk D. F. H. Schallig verfasserin aut In Antibiotics MDPI AG, 2013 10(2021), 4, p 444 (DE-627)726120596 (DE-600)2681345-2 20796382 nnns volume:10 year:2021 number:4, p 444 https://doi.org/10.3390/antibiotics10040444 kostenfrei https://doaj.org/article/25625a380afa46c09898852a92221a7c kostenfrei https://www.mdpi.com/2079-6382/10/4/444 kostenfrei https://doaj.org/toc/2079-6382 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 444 |
allfieldsGer |
10.3390/antibiotics10040444 doi (DE-627)DOAJ074352482 (DE-599)DOAJ25625a380afa46c09898852a92221a7c DE-627 ger DE-627 rakwb eng RM1-950 Massa dit Achille Bonko verfasserin aut Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier (1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< Therapeutics. Pharmacology Palpouguini Lompo verfasserin aut Marc Christian Tahita verfasserin aut Francois Kiemde verfasserin aut Ibrahima Karama verfasserin aut Athanase M. Somé verfasserin aut Petra F. Mens verfasserin aut Sandra Menting verfasserin aut Halidou Tinto verfasserin aut Henk D. F. H. Schallig verfasserin aut In Antibiotics MDPI AG, 2013 10(2021), 4, p 444 (DE-627)726120596 (DE-600)2681345-2 20796382 nnns volume:10 year:2021 number:4, p 444 https://doi.org/10.3390/antibiotics10040444 kostenfrei https://doaj.org/article/25625a380afa46c09898852a92221a7c kostenfrei https://www.mdpi.com/2079-6382/10/4/444 kostenfrei https://doaj.org/toc/2079-6382 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 444 |
allfieldsSound |
10.3390/antibiotics10040444 doi (DE-627)DOAJ074352482 (DE-599)DOAJ25625a380afa46c09898852a92221a7c DE-627 ger DE-627 rakwb eng RM1-950 Massa dit Achille Bonko verfasserin aut Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier (1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< Therapeutics. Pharmacology Palpouguini Lompo verfasserin aut Marc Christian Tahita verfasserin aut Francois Kiemde verfasserin aut Ibrahima Karama verfasserin aut Athanase M. Somé verfasserin aut Petra F. Mens verfasserin aut Sandra Menting verfasserin aut Halidou Tinto verfasserin aut Henk D. F. H. Schallig verfasserin aut In Antibiotics MDPI AG, 2013 10(2021), 4, p 444 (DE-627)726120596 (DE-600)2681345-2 20796382 nnns volume:10 year:2021 number:4, p 444 https://doi.org/10.3390/antibiotics10040444 kostenfrei https://doaj.org/article/25625a380afa46c09898852a92221a7c kostenfrei https://www.mdpi.com/2079-6382/10/4/444 kostenfrei https://doaj.org/toc/2079-6382 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2021 4, p 444 |
language |
English |
source |
In Antibiotics 10(2021), 4, p 444 volume:10 year:2021 number:4, p 444 |
sourceStr |
In Antibiotics 10(2021), 4, p 444 volume:10 year:2021 number:4, p 444 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< Therapeutics. Pharmacology |
isfreeaccess_bool |
true |
container_title |
Antibiotics |
authorswithroles_txt_mv |
Massa dit Achille Bonko @@aut@@ Palpouguini Lompo @@aut@@ Marc Christian Tahita @@aut@@ Francois Kiemde @@aut@@ Ibrahima Karama @@aut@@ Athanase M. Somé @@aut@@ Petra F. Mens @@aut@@ Sandra Menting @@aut@@ Halidou Tinto @@aut@@ Henk D. F. H. Schallig @@aut@@ |
publishDateDaySort_date |
2021-01-01T00:00:00Z |
hierarchy_top_id |
726120596 |
id |
DOAJ074352482 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ074352482</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240412184040.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/antibiotics10040444</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ074352482</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ25625a380afa46c09898852a92221a7c</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Massa dit Achille Bonko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">(1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antibiotics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">nasopharynx</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Streptococcus pneumoniae</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Staphylococcus aureus</i<</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Palpouguini Lompo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marc Christian Tahita</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Francois Kiemde</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ibrahima Karama</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Athanase M. Somé</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Petra F. Mens</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sandra Menting</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Halidou Tinto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Henk D. F. H. Schallig</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Antibiotics</subfield><subfield code="d">MDPI AG, 2013</subfield><subfield code="g">10(2021), 4, p 444</subfield><subfield code="w">(DE-627)726120596</subfield><subfield code="w">(DE-600)2681345-2</subfield><subfield code="x">20796382</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:4, p 444</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/antibiotics10040444</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/25625a380afa46c09898852a92221a7c</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2079-6382/10/4/444</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2079-6382</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2021</subfield><subfield code="e">4, p 444</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Massa dit Achille Bonko |
spellingShingle |
Massa dit Achille Bonko misc RM1-950 misc antibiotics misc resistance misc nasopharynx misc children misc <i<Streptococcus pneumoniae</i< misc <i<Staphylococcus aureus</i< misc Therapeutics. Pharmacology Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso |
authorStr |
Massa dit Achille Bonko |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)726120596 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RM1-950 |
illustrated |
Not Illustrated |
issn |
20796382 |
topic_title |
RM1-950 Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso antibiotics resistance nasopharynx children <i<Streptococcus pneumoniae</i< <i<Staphylococcus aureus</i< |
topic |
misc RM1-950 misc antibiotics misc resistance misc nasopharynx misc children misc <i<Streptococcus pneumoniae</i< misc <i<Staphylococcus aureus</i< misc Therapeutics. Pharmacology |
topic_unstemmed |
misc RM1-950 misc antibiotics misc resistance misc nasopharynx misc children misc <i<Streptococcus pneumoniae</i< misc <i<Staphylococcus aureus</i< misc Therapeutics. Pharmacology |
topic_browse |
misc RM1-950 misc antibiotics misc resistance misc nasopharynx misc children misc <i<Streptococcus pneumoniae</i< misc <i<Staphylococcus aureus</i< misc Therapeutics. Pharmacology |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Antibiotics |
hierarchy_parent_id |
726120596 |
hierarchy_top_title |
Antibiotics |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)726120596 (DE-600)2681345-2 |
title |
Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso |
ctrlnum |
(DE-627)DOAJ074352482 (DE-599)DOAJ25625a380afa46c09898852a92221a7c |
title_full |
Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso |
author_sort |
Massa dit Achille Bonko |
journal |
Antibiotics |
journalStr |
Antibiotics |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2021 |
contenttype_str_mv |
txt |
author_browse |
Massa dit Achille Bonko Palpouguini Lompo Marc Christian Tahita Francois Kiemde Ibrahima Karama Athanase M. Somé Petra F. Mens Sandra Menting Halidou Tinto Henk D. F. H. Schallig |
container_volume |
10 |
class |
RM1-950 |
format_se |
Elektronische Aufsätze |
author-letter |
Massa dit Achille Bonko |
doi_str_mv |
10.3390/antibiotics10040444 |
author2-role |
verfasserin |
title_sort |
antibiotic susceptibility of <i<staphylococcus aureus</i< and <i<streptococcus pneumoniae</i< isolates from the nasopharynx of febrile children under 5 years in nanoro, burkina faso |
callnumber |
RM1-950 |
title_auth |
Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso |
abstract |
(1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. |
abstractGer |
(1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. |
abstract_unstemmed |
(1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
4, p 444 |
title_short |
Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso |
url |
https://doi.org/10.3390/antibiotics10040444 https://doaj.org/article/25625a380afa46c09898852a92221a7c https://www.mdpi.com/2079-6382/10/4/444 https://doaj.org/toc/2079-6382 |
remote_bool |
true |
author2 |
Palpouguini Lompo Marc Christian Tahita Francois Kiemde Ibrahima Karama Athanase M. Somé Petra F. Mens Sandra Menting Halidou Tinto Henk D. F. H. Schallig |
author2Str |
Palpouguini Lompo Marc Christian Tahita Francois Kiemde Ibrahima Karama Athanase M. Somé Petra F. Mens Sandra Menting Halidou Tinto Henk D. F. H. Schallig |
ppnlink |
726120596 |
callnumber-subject |
RM - Therapeutics and Pharmacology |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3390/antibiotics10040444 |
callnumber-a |
RM1-950 |
up_date |
2024-07-03T22:40:38.794Z |
_version_ |
1803599414605905922 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ074352482</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240412184040.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/antibiotics10040444</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ074352482</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ25625a380afa46c09898852a92221a7c</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Massa dit Achille Bonko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antibiotic Susceptibility of <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">(1) Background: nasopharynx colonization by resistant <i<Staphylococcus aureus</i< and <i<Streptococcus pneumoniae</i< can lead to serious diseases. Emerging resistance to antibiotics commonly used to treat infections due to these pathogens poses a serious threat to the health system. The present study aimed to determine the antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates from the febrile children’s nasopharynx under 5 years in Nanoro (Burkina Faso). (2) Methods: bacterial isolates were identified from nasopharyngeal swabs prospectively collected from 629 febrile children. Antibiotic susceptibility of <i<S. aureus</i< and <i<S. pneumoniae</i< isolates was assessed by Kirby–Bauer method and results were interpreted according to the Clinical and Laboratory Standard Institute guidelines. (3) Results: bacterial colonization was confirmed in 154 (24.5%) of children of whom 96.1% carried <i<S. aureus</i<, 3.2% had <i<S. pneumoniae</i<, and 0.6% carried both bacteria. <i<S. aureus</i< isolates showed alarming resistance to penicillin (96.0%) and <i<S. pneumoniae</i< was highly resistant to tetracycline (100%) and trimethoprim–sulfamethoxazole (83.3%), and moderately resistant to penicillin (50.0%). Furthermore, 4.0% of S. aureus identified were methicillin resistant. (4) Conclusion: this study showed concerning resistance rates to antibiotics to treat suspected bacterial respiratory tract infections. The work highlights the necessity to implement continuous antibiotic resistance surveillance.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antibiotics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">nasopharynx</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Streptococcus pneumoniae</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Staphylococcus aureus</i<</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Palpouguini Lompo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marc Christian Tahita</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Francois Kiemde</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ibrahima Karama</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Athanase M. Somé</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Petra F. Mens</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sandra Menting</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Halidou Tinto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Henk D. F. H. Schallig</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Antibiotics</subfield><subfield code="d">MDPI AG, 2013</subfield><subfield code="g">10(2021), 4, p 444</subfield><subfield code="w">(DE-627)726120596</subfield><subfield code="w">(DE-600)2681345-2</subfield><subfield code="x">20796382</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:4, p 444</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/antibiotics10040444</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/25625a380afa46c09898852a92221a7c</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2079-6382/10/4/444</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2079-6382</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2021</subfield><subfield code="e">4, p 444</subfield></datafield></record></collection>
|
score |
7.40088 |